Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bleomycin vs VEGF inhibitor injections for extremity vascular anomalies
TCTR20240524002Phase 3Recruiting
- Sponsor
- Siriraj Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of bleomycin in vascular abnormality (2 arms), sponsored by Siriraj Hospital. Started Apr 2024; status: recruiting.
02
Drugs
bleomycin
03
Conditions
vascular abnormality
Beyond the preview
Go deeper on TCTR20240524002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240524002.